Cargando…

The Role of Costimulatory Receptors of the Tumour Necrosis Factor Receptor Family in Atherosclerosis

Atherosclerosis is a chronic inflammatory disease that is mediated by both the innate and adaptive immune responses. T lymphocytes, that together with B cells are the cellular effectors of the adaptive immune system, are currently endowed with crucial roles in the development and progression of athe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antunes, Ricardo F., Kaski, Juan Carlos, Dumitriu, Ingrid E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253462/ https://www.ncbi.nlm.nih.gov/pubmed/22235167 http://dx.doi.org/10.1155/2012/464532

Ejemplares similares

Targeting T cells to treat atherosclerosis: odyssey from bench to bedside
por: Bullenkamp, Jessica, et al.
Publicado: (2016)

Association of soluble interleukin‐2 receptor α and tumour necrosis factor receptor 1 with heart failure: The Multi‐Ethnic Study of Atherosclerosis
por: Bakhshi, Hooman, et al.
Publicado: (2020)

Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis
por: Glossop, John R, et al.
Publicado: (2005)

Uveitis Therapy With Shark Variable Novel Antigen Receptor Domains Targeting Tumor Necrosis Factor Alpha or Inducible T-Cell Costimulatory Ligand
por: Pepple, Kathryn L., et al.
Publicado: (2019)

Costimulatory and coinhibitory molecules of B7-CD28 family in cardiovascular atherosclerosis: A review
por: Yang, Mao, et al.
Publicado: (2022)

Pharmacodynamic analysis of an agonistic antibody to the costimulatory receptor GITR
por: Moody, Gordon, et al.
Publicado: (2015)

Glucocorticoid-induced tumour necrosis factor receptor family-related protein (GITR) drives atherosclerosis in mice and is associated with an unstable plaque phenotype and cerebrovascular events in humans
por: Shami, Annelie, et al.
Publicado: (2020)

The costimulatory receptor B7-1 is not induced in injured podocytes
por: Baye, Emilie, et al.
Publicado: (2016)

Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor.
por: Trentin, L., et al.
Publicado: (1995)

Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerations
por: Weinkove, Robert, et al.
Publicado: (2019)

Living with Tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS)
por: Dandekar, P, et al.
Publicado: (2015)

Expression of tumour necrosis factor alpha and its receptors in carcinoma of the breast.
por: Pusztai, L., et al.
Publicado: (1994)

Induction of soluble tumour necrosis factor receptors during treatment with interleukin-2.
por: Miles, D. W., et al.
Publicado: (1992)

Higher serum levels of tumour necrosis factor and its soluble receptors are associated with ovarian tumours
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2012)

CD95 as a negative or positive costimulatory receptor for primary T cell activation
por: Paulsen, M, et al.
Publicado: (2009)

Multiple mechanisms for TRAF3-mediated regulation of the T cell costimulatory receptor GITR
por: Li, Hanzeng, et al.
Publicado: (2021)

Opioid receptor expression on neutrophils: effect of tumour necrosis factor alpha treatment
por: Schmidt, A, et al.
Publicado: (2007)

Soluble tumour necrosis factor receptor type II and survival in colorectal cancer
por: Babic, Ana, et al.
Publicado: (2016)

Therapeutic inhibition of tumour necrosis factor alpha reduces oligoclonality in the selected T-cell receptor BV families in rheumatoid arthritis
por: Pierer, M, et al.
Publicado: (2003)

Tumor necrosis family receptor superfamily member 9/tumor necrosis factor receptor-associated factor 1 pathway on hepatitis C viral persistence and natural history
por: Peña-Asensio, Julia, et al.
Publicado: (2020)

CD43 is a murine T cell costimulatory receptor that functions independently of CD28
Publicado: (1995)

An In Vitro Comparison of Costimulatory Domains in Chimeric Antigen Receptor T Cell for Breast Cancer Treatment
por: Khuisangeam, Nattarika, et al.
Publicado: (2022)

Tumor Necrosis Factor Receptor Associated Factor 6 Is Not Required for Atherogenesis in Mice and Does Not Associate with Atherosclerosis in Humans
por: Stachon, Peter, et al.
Publicado: (2010)

Costimulatory pathways in transplantation
por: Pilat, Nina, et al.
Publicado: (2011)

Development of Allergic Inflammation in a Murine Model of Asthma Is Dependent on the Costimulatory Receptor Ox40
por: Jember, Amha Gebre-Hiwot, et al.
Publicado: (2001)

The role of costimulatory molecules in glioma biology and immune microenvironment
por: Wang, Ji, et al.
Publicado: (2022)

Boosting Antitumor Response by Costimulatory Strategies Driven to 4-1BB and OX40 T-cell Receptors
por: Mascarelli, Daniele E., et al.
Publicado: (2021)

Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma.
por: Leek, R. D., et al.
Publicado: (1998)

Natural antisense RNA inhibits the expression of BCMA, a tumour necrosis factor receptor homologue.
por: Hatzoglou, Anastassia, et al.
Publicado: (2002)

The Role of Tumor Necrosis Factor Associated Factors (TRAFs) in Vascular Inflammation and Atherosclerosis
por: Gissler, Mark Colin, et al.
Publicado: (2022)

First Report of Circulating MicroRNAs in Tumour Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS)
por: Lucherini, Orso Maria, et al.
Publicado: (2013)

CD95 ligand - death factor and costimulatory molecule?
por: Janssen, O, et al.
Publicado: (2003)

Serial measurement of the circulating levels of tumour necrosis factor and its soluble receptors 1 and 2 for monitoring leprosy patients during multidrug treatment
por: Costa, Rosane Dias, et al.
Publicado: (2013)

The Relationship of Fever to Tumour Necrosis in the Rat
por: Allen, Ingrid V.
Publicado: (1964)

Secondary amyloidosis in a patient carrying mutations in the familial Mediterranean fever (FMF) and tumour necrosis factor receptor-1 syndrome (TRAPS) genes
por: Clementi, Anna, et al.
Publicado: (2013)

Deficiency for Costimulatory Receptor 4-1BB Protects Against Obesity-Induced Inflammation and Metabolic Disorders
por: Kim, Chu-Sook, et al.
Publicado: (2011)

Toll-Like Receptor Ligands Induce Expression of the Costimulatory Molecule CD155 on Antigen-Presenting Cells
por: Kamran, Neha, et al.
Publicado: (2013)

4-1BB (CD137), an inducible costimulatory receptor, as a specific target for cancer therapy
por: Vinay, Dass S., et al.
Publicado: (2014)

Biomimetic nanoparticles deliver mRNAs encoding costimulatory receptors and enhance T cell mediated cancer immunotherapy
por: Li, Wenqing, et al.
Publicado: (2021)

The homodimer interfaces of costimulatory receptors B7 and CD28 control their engagement and pro-inflammatory signaling
por: Popugailo, Andrey, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o8dkkblehubgv230vujmig8m3i